Phase I – Other

1,064 trials 249 recruiting

Filter these 1,064 trials by condition, country, sponsor and more.

Open in Search →

A Phase I study to evaluate the pharmacokinetics, safety and tolerability of multiple oral doses of obefazimod in participants with renal im… Ended

2024-514561-20-00 Moderately to severely active ulcerative colitis 2024-09-09
A research study to evaluate the effects of single doses of NNC0614-0001 in healthy adult volunteers, and participants with hereditary haemo… Ended

2023-504574-38-00 Hereditary haemochromatosis (HH) type 1 2024-09-06
A study on the effects of a new drug on the sensitivity of the nerves in healthy volunteers Ended

2024-515390-99-00 Hyperexcitability nerve disorder 2024-09-06
A study to learn how much minzasolmin gets into the body when taken in different ways and how safe it is in healthy adults Ended

2024-511301-31-00 Healthy Participants 2024-09-06
A study to test whether BI 456906 (survodutide) influences the amount of bupropion, caffeine and midazolam in the blood in people with overw… Ended

2024-512332-29-00 Overweight 2024-09-05
A TQT Study to Investigate the Effect of Enpatoran on Cardiac Repolarization in Healthy Participants Ended

2024-512841-17-00 Healthy 2024-09-04
Effect of Renal Impairment on Enpatoran Pharmacokinetics Ended

2024-513393-22-00 Healthy volunteers and patients with renal impairment; 2024-09-04
Exploratory Bioavailability of Three Formulations of Gliclazide MR Tablets 120 mg (I.R.I.S.) in Healthy Volunteers Under Fed Conditions (Hig… Ended

2024-514298-23-00 No medical condicion. 2024-09-02
PET study of changes in [11C]AZ14132516 uptake following administration of multiple AZD7798 doses to patients with Crohn’s disease. Ended

2024-512992-11-00 Crohn's disease 2024-08-30
A Phase 1, Open-Label, Multiple-Part Trial to Evaluate the Drug-Drug Interaction Potential of PRAX-628 in Healthy Participants Ended

2024-514426-23-01 Epilepsy 2024-08-28
Phase Ib Clinical Trial to Evaluate the Safety Profile of the Combination Tilray FS Oral Solution T10:C10 with Temozolomide and Radiotherapy… Ended

2024-515546-16-00 Glioblastoma 2024-08-27
A study in healthy men to test how BI 1569912 is processed in the body Ended

2023-510464-12-00 Healthy volunteer trial 2024-08-26
Safety Study to Compare the Gastrointestinal Tolerability of Oral Tegomil Fumarate and Dimethyl Fumarate (Tecfidera®) in Healthy Volunteers. Ended

2023-508439-30-00 Multiple Sclerosis 2024-08-21
A study in healthy men to test whether zongertinib influences the amount of 4 other medicines (dabigatran, rosuvastatin, metformin, and furo… Ended

2024-510628-38-00 Pharmacokinetic trial 2024-08-19
A study to investigate VMX-C001 in healthy volunteers. Ended

2024-514339-87-00 To restore coagulation in patients taking DOACs who are 2024-08-14
Evaluation of vamorolone CYP3A4 induction on midazolam (a sensitive CYP3A4 substrate) pharmacokinetics Ended

2024-513845-36-00 Phase I study in healthy male volunteers. Intended indi 2024-08-13
A Phase I, open-label, fixed sequence drug interaction study in healthy subjects to investigate the effect of a 40 mg deucrictibant tablet a… Ended

2024-514713-35-00 Hereditary angioedema 2024-08-08
A study to learn about the safety of BAY 3283142 in people with mild to moderate high blood pressure Ended

2024-512060-58-00 Chronic kidney disease 2024-08-07
A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED PHASE I TRIAL TO INVESTIGATE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SINGLE ASCENDING TO… Ended

2024-512893-86-00 Actinic keratosis 2024-08-06
Open label, single-center, two-part pharmacokinetic study: Part I: Relative bioavailability study to compare the pharmacokinetics of BP1.497… Ended

2024-512355-20-00 Binge eating disorder 2024-08-01
A study to test how well healthy people tolerate spesolimab when given in 2 different ways. Ended

2023-510448-20-00 Healthy volunteer trial 2024-07-30
A study to learn about the amount of asundexian in the blood when healthy participants take different types of asundexian tablets Ended

2023-509447-28-00 Prevention of ischemic stroke in patients post acute no 2024-07-26
A research study of how safe a new medicine called NNC0519‑0130 is and to test its effect in people living with excess body weight with or w… Ended

2024-512719-28-00 Obesity, Type 2 Diabetes with either overweight or obes 2024-07-25
Study to assess the safety, pharmacokinetics and efficacy of HMPL-523 in patients with Immune Thrombocytopenia Ended

2023-508819-23-00 Primary immune thrombocytopenia (ITP) 2024-07-24